Standigm announces partnership with Ajou University College of Pharmacy to discover a new small molecule drug for Parkinson’s disease.

Updated:

Standigm and Ajou university college of pharmacy announced a research collaboration to develop a new small molecule medicine for Parkinson’s disease. Under this partnership, Standigm will provide AI-driven drugs for Parkinson’s disease, and Ajou university college of pharmacy will validate them experimentally.

Tags: AI-driven drug discovery , Ajou university , Artificial intelligence , Parkinson's disease , Standigm

Categories: News